| Application no. and date | 22740800.2 (espacenet) (Federated) (European Patent Register), 20220624 | | Patent/reg. no. and date | DK/EP 4284387, 20240731 | | Publication date | 20231206 | | Priority no. and date | GB 202109138, 20210624, GB 202200883, 20220124, GR 20220100277, 20220329 | | EP pub. no. and date |
EP 4284387 20231206 | | Effective date | | | Applicant/owner | VESTLANDETS INNOVASJONSSELSKAP AS (VIS), Thormøhlensgate 51
5006 Bergen, NO | | Applicant ref. no. | P85031DK01 | | Inventor | TZOULIS, Charalampos,
5021 Bergen, NO,
DÖLLE, Christian,
5021 Bergen, NO | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/198 (2006.01) , A61K 31/706 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 25/16 (2006.01) | | Title | NAD-FORSTÆRKELSESTERAPI TIL PARKINSONS SYGDOM | | Int. application no. | EP2022067412 | | Int. publication no. | WO2022269066 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
